Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel P Hermans

Showing results (31-40 of 122) with videos related to

Pageof 13
Sort By:
Acta Cardiologica|May 30, 2009
Centralized Pan-European survey on the undertreatment of hypercholesterolaemia (CEPHEUS)Michel P Hermans, Walter Van Mieghem, Guy Vandenhoven, et al.
Endocrine Connections|October 21, 2025
Cardiometabolic insights in cystic fibrosis and highly effective modulator therapies: a narrative reviewFabian O Lurquin, Michel P Hermans, Sophie Gohy, et al.
Archives of Cardiovascular Diseases|December 2, 2008
Assessment of lipid-lowering treatment in France--the CEPHEUS studyJean Ferrières, Elisabeth Tocque-Le Gousse, Caroline Fabry, et al.
Diabetes/Metabolism Research and Reviews|September 19, 2017
[HDL-C/apoA-I]: A multivessel cardiometabolic risk marker in women with T2DMMichel P Hermans, Paul Valensi, Sylvie A Ahn, et al.
Current Atherosclerosis Reports|January 4, 2021
Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα) in the Metabolic Syndrome: Is Pemafibrate Light at the End of the Tunnel?Jean-Charles Fruchart, Michel P Hermans, Jamila Fruchart-Najib, et al.
Diabetes/Metabolism Research and Reviews|June 27, 2015
How to transform a metabolic syndrome score into an insulin sensitivity value?Michel P Hermans, Evariste Bouenizabila, Sylvie A Ahn, et al.
Diabetes & Metabolic Syndrome|January 16, 2019
High rates of atherogenic dyslipidemia, β-cell function loss, and microangiopathy among Turkish migrants with T2DMMichel P Hermans, Sylvie A Ahn, Shaukat Sadikot, et al.
Diabetes & Metabolic Syndrome|August 16, 2020
Established and novel gender dimorphisms in type 2 diabetes mellitus: Insights from a multiethnic cohortMichel P Hermans, Sylvie A Ahn, Shaukat Sadikot, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|August 11, 2010
Raised plasma urotensin II in type 2 diabetes patients is associated with the metabolic syndrome phenotypeDamien Gruson, Michel F Rousseau, Jean-Marie Ketelslegers, et al.
Diabetes/Metabolism Research and Reviews|January 4, 2013
Sleep apnoea syndrome and 10-year cardiovascular risk in females with type 2 diabetes: relationship with insulin secretion and insulin resistanceMichel P Hermans, Sylvie A Ahn, Yovan P Mahadeb, et al.
Pageof 13

Showing results (31-40 of 122) with videos related to

Sort By:
Pageof 13
Acta Cardiologica|May 30, 2009
Centralized Pan-European survey on the undertreatment of hypercholesterolaemia (CEPHEUS)Michel P Hermans, Walter Van Mieghem, Guy Vandenhoven, et al.
Endocrine Connections|October 21, 2025
Cardiometabolic insights in cystic fibrosis and highly effective modulator therapies: a narrative reviewFabian O Lurquin, Michel P Hermans, Sophie Gohy, et al.
Archives of Cardiovascular Diseases|December 2, 2008
Assessment of lipid-lowering treatment in France--the CEPHEUS studyJean Ferrières, Elisabeth Tocque-Le Gousse, Caroline Fabry, et al.
Diabetes/Metabolism Research and Reviews|September 19, 2017
[HDL-C/apoA-I]: A multivessel cardiometabolic risk marker in women with T2DMMichel P Hermans, Paul Valensi, Sylvie A Ahn, et al.
Current Atherosclerosis Reports|January 4, 2021
Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα) in the Metabolic Syndrome: Is Pemafibrate Light at the End of the Tunnel?Jean-Charles Fruchart, Michel P Hermans, Jamila Fruchart-Najib, et al.
Diabetes/Metabolism Research and Reviews|June 27, 2015
How to transform a metabolic syndrome score into an insulin sensitivity value?Michel P Hermans, Evariste Bouenizabila, Sylvie A Ahn, et al.
Diabetes & Metabolic Syndrome|January 16, 2019
High rates of atherogenic dyslipidemia, β-cell function loss, and microangiopathy among Turkish migrants with T2DMMichel P Hermans, Sylvie A Ahn, Shaukat Sadikot, et al.
Diabetes & Metabolic Syndrome|August 16, 2020
Established and novel gender dimorphisms in type 2 diabetes mellitus: Insights from a multiethnic cohortMichel P Hermans, Sylvie A Ahn, Shaukat Sadikot, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|August 11, 2010
Raised plasma urotensin II in type 2 diabetes patients is associated with the metabolic syndrome phenotypeDamien Gruson, Michel F Rousseau, Jean-Marie Ketelslegers, et al.
Diabetes/Metabolism Research and Reviews|January 4, 2013
Sleep apnoea syndrome and 10-year cardiovascular risk in females with type 2 diabetes: relationship with insulin secretion and insulin resistanceMichel P Hermans, Sylvie A Ahn, Yovan P Mahadeb, et al.
Pageof 13